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Abstract
The calcium-gated potassium channel SLO-1 in Caenorhabditis elegans was recently identified as key component for action
of emodepside, a new anthelmintic drug with broad spectrum activity. In this study we identified orthologues of slo-1 in
Ancylostoma caninum, Cooperia oncophora, and Haemonchus contortus, all important parasitic nematodes in veterinary
medicine. Furthermore, functional analyses of these slo-1 orthologues were performed using heterologous expression in C.
elegans. We expressed A. caninum and C. oncophora slo-1 in the emodepside-resistant genetic background of the slo-1 loss-
of-function mutant NM1968 slo-1(js379). Transformants expressing A. caninum slo-1 from C. elegans slo-1 promoter were
highly susceptible (compared to the fully emodepside-resistant slo-1(js379)) and showed no significant difference in their
emodepside susceptibility compared to wild-type C. elegans (p = 0.831). Therefore, the SLO-1 channels of A. caninum and C.
elegans appear to be completely functionally interchangeable in terms of emodepside sensitivity. Furthermore, we tested
the ability of the 59 flanking regions of A. caninum and C. oncophora slo-1 to drive expression of SLO-1 in C. elegans and
confirmed functionality of the putative promoters in this heterologous system. For all transgenic lines tested, expression of
either native C. elegans slo-1 or the parasite-derived orthologue rescued emodepside sensitivity in slo-1(js379) and the
locomotor phenotype of increased reversal frequency confirming the reconstitution of SLO-1 function in the locomotor
circuits. A potent mammalian SLO-1 channel inhibitor, penitrem A, showed emodepside antagonising effects in A. caninum
and C. elegans. The study combined the investigation of new anthelmintic targets from parasitic nematodes and
experimental use of the respective target genes in C. elegans, therefore closing the gap between research approaches using
model nematodes and those using target organisms. Considering the still scarcely advanced techniques for genetic
engineering of parasitic nematodes, the presented method provides an excellent opportunity for examining the
pharmacofunction of anthelmintic targets derived from parasitic nematodes.
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Introduction
Infections with parasitic nematodes heavily affect the well-being,
health, and productivity of humans and animals worldwide [1].
Since the 1960s several broad spectrum anthelmintic compounds
have been available. During decades of frequent and sometimes
inappropriate use of these anthelmintics, resistance to currently
available drugs has developed and is an increasing problem in
parasitic nematodes, especially in livestock [2]. In human
medicine, where mass anthelmintic treatment programmes were
employed during recent years in countries with endemic gastro-
intestinal nematode infections, there is also growing concern
regarding anthelmintic resistance, and several reports of treatment
failure were published during recent years [3-6]. In livestock non-
chemical worm control procedures such as pasture management,
feeding, and breeding are being tested, but they are cost- and
labour-intensive and often not practical [7]. In parasites of
companion animals, resistance is less common. Nevertheless,
populations of the canine hookworm Ancylostoma caninum were
recently reported to show high degrees of resistance to pyrantel
[8]. Therefore, the need for anthelmintic compounds with new
modes of action is urgent.
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Recently, three groups of anthelmintic compounds employing
new mechanisms of action have been introduced. The oxindole
alkaloid paraherquamide was described first in 1981 [9].
Paraherquamide and its derivative 2-deoxoparaherquamide (der-
quantel) are anthelmintically active by blocking acetylcholine
receptors and therefore inhibiting neurotransmission [10,11].
Derquantel has been launched in combination with abamectin
as a drench for sheep in New Zealand in 2010. The combination
showed high efficacies against field infections with strongyles in
sheep [12]. The second group, comprising the amino-acetonitrile
derivatives (AAD), was recently reported to act mainly through the
nicotinic acetylcholine receptor ACR-23. This receptor is not
present in mammals and is not involved in the action of
levamisole, ivermectin, benomyl, dimethyl-4-phenylpiperazinium,
and aldicarb. The derivative AAD 1470 was shown to have good
efficacy against different species of gastrointestinal nematodes [13].
The first available AAD on the market was AAD 1566
(monepantel), which has been launched as a sheep drench. The
third group are the cyclooctadepsipeptides. The parent compound
of this class is PF1022A, which was discovered as a fermentation
product of the fungus Mycelia sterilia [14]. The semi-synthetic
derivative emodepside has a broad spectrum of anthelmintic
activity [15], indicating that the mechanism of action might be
conserved throughout nematode clades. Emodepside and
PF1022A were also shown to be effective against anthelmintic-
resistant populations of the sheep nematode Haemonchus contortus
and the cattle nematode Cooperia oncophora [16]. Commercially,
emodepside was first available as a spot-on preparation in
combination with praziquantel for cats. Recently, emodepside
has been launched as a tablet for dogs, also in combination with
praziquantel.
In Caenorhabditis elegans, emodepside potently inhibits locomo-
tion, egg-laying, and pharyngeal pumping [17]. Previous studies
identified nematode latrophilin (LAT-1) as a target for emodepside
[18,19], but LAT-1 is not required for the inhibitory effects of
emodepside on locomotion [19,20]. Indeed, a mutagenesis screen
revealed the large conductance calcium-gated potassium channel
SLO-1 as a key component for the mechanisms of action of
emodepside [20]. SLO-1 channels are regulated by voltage and by
intracellular concentration of calcium ions [21–24]. They were
first identified in experiments with the slowpoke mutant of Drosophila
melanogaster, which exhibits abnormal locomotory behaviour and
decreased flight ability [22,24]. In C. elegans, SLO-1 was previously
shown to control excitatory neurotransmitter release. It is
expressed in the nerve ring and in the body wall muscle [21].
The slo-1 loss-of-function mutants show a characteristic locomotor
phenotype consisting of an increase in locomotor reversal
frequency [20,21]. The mutagenesis screen for emodepside-
resistant C. elegans mentioned above revealed nine independent
lines that were able to move and to reproduce on agar plates with
an emodepside concentration as high as 1 mM, a concentration
that immobilises wild-type C. elegans. All nine lines fell into a single
complementation group that mapped closely to the slo-1 locus on
chromosome V. Four of them were sequenced and showed
mutations in the slo-1 locus predicted to lead to a reduced or
abolished function of the channel. In locomotion assays, the slo-1
mutants had different degrees of resistance to emodepside.
Reduction-of-function mutants showed reduced susceptibility to
emodepside whilst loss-of-function mutants were not at all
inhibited after exposure to emodepside [20]. The putative slo-1
null allele reference strain NM1968 slo-1(js379)V [21] was also
highly resistant to emodepside. The expression of slo-1 in slo-
1(js379) animals from the pan-neuronal promoter snb-1 [21,25]
and the muscle cell-specific promoter myo-3 [21,26], either in
combination or separately, restored emodepside susceptibility to
different degrees [20].
In this study, we identified slo-1 orthologues in H. contortus, A.
caninum and C. oncophora. The slo-1 coding sequences of A. caninum
and C. oncophora were subsequently expressed in the emodepside-
resistant C. elegans strain slo-1(js379) to investigate their ability to
rescue emodepside susceptibility of slo-1 loss-of-function mutants.
Furthermore, we compared the ability of different C. elegans
promoters as well as the slo-1 59 flanking regions of A. caninum and
C. oncophora to drive expression of slo-1 in slo-1 loss-of-function
mutants and examined the locomotor phenotype as well as the
degree of emodepside susceptibility in the transformants. Finally,
we showed that penitrem A, an inhibitor of mammalian SLO-
channels [27], is able to antagonise the paralysing effect of
emodepside on infective A. caninum larvae as well as on the
locomotion of young C. elegans adults in a dose-dependent manner.
Materials and Methods
Parasites
The animals used for the maintenance of the parasitic nematode
strains were helminth-free prior to infection. All animals used in
this study were handled in strict accordance with good animal
practice as defined by the relevant national and local animal
welfare bodies, and all animal work was approved by the
appropriate committee. Calves were infected with approx.
30,000 C. oncophora third-stage larvae, and sheep were infected
with 6,000-8,000 infective larvae of H. contortus. After 21 to 30
days, the animals were necropsied, and the small intestine or the
abomasum, respectively, was removed. The worms were either
washed off or picked directly from the mucosa. Dogs were infected
with 400-500 infective A. caninum larvae. After reaching patency,
the dogs were treated with 4 mg/kg arecoline. The subsequently
deposited faeces were collected and sieved through a 100 mm mesh
sieve. The adult A. caninum were picked directly from the sieve.
The recovered parasites were sorted according to sex, washed in
0.9% NaCl solution and subsequently in DEPC-treated water.
Author Summary
In parasitic nematodes, experiments at the molecular level
are currently not feasible, since in vitro culture and genetic
engineering are still in their infancy. In the present study
we chose the model organism Caenorhabditis elegans not
only as a mere expression system for genes from parasitic
nematodes, but used the transformants to examine the
functionality of the expressed proteins for mediating
anthelmintic effects in vivo. The results of our experiments
confirmed that SLO-1 channels mediate the activity of the
new anthelmintic drug emodepside and showed that the
mode of action is conserved through several nematode
species. The chosen method allowed us to examine the
functionality of proteins from parasitic nematodes in a
defined genetic background. Notably, expression of the
parasitic nematode gene in anthelmintic-resistant C.
elegans completely restored drug susceptibility. As C.
elegans is highly tractable to molecular genetic and
pharmacological approaches, the generation of lines
expressing the parasite drug target will greatly facilitate
structure-function analysis of the interaction between
emodepside and ion channels with direct relevance to its
anthelmintic properties. In a broader context, the demon-
stration of C. elegans as a heterologous expression system
for functional analysis of parasite proteins further strength-
ens this as a model for anthelmintic studies.
Parasitic Nematode SLO-1-Channels and Emodepside
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The worms were frozen at -80uC in sterile GIT buffer (4 M
guanidine; 0.1 M Tris, pH 7.5; 1% b-mercapto-ethanol).
Ethics statement
All experiments with animals were performed in strict
accordance to the German law for animal welfare (Tierschutzge-
setz) and with the approval of the respective local authority, the
Niedersa¨chsisches Landesamt fu¨r Verbraucherschutz und Lebens-
mittelsicherheit (LAVES) under the reference numbers 01A38,
01A48 and 06A395. All efforts were made to avoid and minimize
suffering of the animals.
Sequences and constructs
Total RNA was isolated using Trizol reagent (Invitrogen,
Karlsruhe, Germany), according to the manufacturer’s recom-
mendations. For cDNA synthesis and Rapid Amplification of
cDNA Ends (RACE), the BD SMART RACE cDNA Amplifica-
tion Kit (Clontech, St-Germain-en-Laye, France) was used
following the manual. For isolation of genomic DNA, a standard
phenol-chloroform method was used [28]. The GenomeWalker
Universal Kit (Clontech) was used to amplify the putative slo-1
promoter regions of A. caninum and C. oncophora. Primers to amplify
the putative C. elegans slo-1 promoter region were designed based
on the sequence of YAC clone Y51A2D (GenBank Acc. No.
AL021497). The first primers for fragments of the slo-1 coding
sequence of H. contortus were designed based on EST (Expressed
Sequence Tag) sequences revealed by the H. contortus EST Basic
Local Alignment Search Tool (BLAST) of the Wellcome Trust
Sanger Institute server, using the C. elegans slo-1 sequence
(GenBank Acc. No. NM_001029089, accordant with slo-1 splice
variant b) as template. The same primers were used to amplify a
partial slo-1 coding sequence of C. oncophora. Primers for A. caninum
slo-1 were designed based on a partial coding sequence detected in
the whole genome shotgun library AIAAGSS 001 using the
BLAST application of the Nematode Net [29]. Sequences of
primers are given as supporting data, Table S1. PCR products
were cloned into the pCR4-TOPO vector, using the TOPO TA
Cloning Kit (Invitrogen) or into the pCR-Blunt vector, using the
Zero Blunt PCR Cloning Kit (Invitrogen) and transformed into
TOP10 Escherichia coli cells (Invitrogen). Vectors containing full-
length slo-1 coding sequences were transformed into JM109 E. coli
cells (Stratagene, La Jolla, CA, USA). Plasmid DNA preparation
was performed using the NucleoSpin Plasmid Kit or the
NucleoBond AX 100 Kit (Macherey and Nagel, Du¨ren,
Germany). To introduce the required restriction sites, PCR was
performed using primers carrying the restriction sites (refer to
supporting data, Table S1) with a plasmid, containing the
respective full-length sequence, or with cDNA as template. The
PCR products were cloned as described above and subcloned into
the respective expression vector using T4 DNA ligase (Invitrogen).
The basis of the expression plasmids was pBK3.1 [20,21] (kindly
provided by Lawrence Salkoff, Washington University School of
Medicine, St. Louis), carrying the C. elegans slo-1 coding sequence
downstream of the C. elegans snb-1 promoter, leading to neuron
specific expression [21,25]. The expression plasmids were
propagated in XL10-Gold Ultracompetent Cells (Stratagene).
The coding sequences of A. caninum and C. oncophora slo-1,
respectively, were cloned between the XbaI and BamHI restriction
sites within the pBK3.1, thus replacing the C. elegans slo-1 coding
sequence. To test the functionality of the slo-1 coding sequences to
be analysed in as natural an expression pattern as possible,
constructs were built carrying the slo-1 coding sequences
downstream of the C. elegans slo-1 promoter. To achieve a
construct carrying the C. elegans slo-1 promoter and the C. elegans
slo-1 coding sequence, a ligation was set up with three DNA
fragments, since the coding sequence of C. elegans slo-1 contained
an additional HindIII restriction site: 1) the vector backbone of
pBK3.1 digested with BamHI/HindIII, 2) the promoter sequence
(HindIII/partial XbaI digest), and 3) the coding sequence of
pBK3.1 digested with XbaI/BamHI. The plasmids carrying the
parasite slo-1 coding sequences downstream of the C. elegans slo-1
promoter were derived by modifying pBK3.1 constructs which
already carried the slo-1 coding sequence of the parasitic
nematodes. The snb-1 promoter was excised and replaced by the
C. elegans slo-1 promoter sequence using the HindIII and XbaI
restriction sites flanking the promoter region. For this purpose, the
plasmid carrying the C. elegans slo-1 promoter sequence had to be
digested completely with HindIII, but only partially with XbaI,
since the promoter sequence had an additional XbaI restriction
site. The plasmid carrying the C. oncophora slo-1 coding sequence
downstream of the C. elegans slo-1 promoter was not used for
functional analysis but as a starting point to construct a plasmid
with the C. oncophora slo-1 coding sequence downstream of the C.
oncophora slo-1 promoter region (see below). To test the function-
ality of the parasite promoter sequences, the parasite promoters
were used to drive expression of the respective parasite slo-1 in C.
elegans. For this purpose, the putative promoters were inserted
between the HindIII and XbaI restriction sites in the modified
pBK3.1 as described above, replacing the C. elegans slo-1 promoter.
Due to additional HindIII and XbaI restriction sites in the C.
oncophora slo-1 promoter sequence, the plasmid construction was
done by blunt end ligation. All plasmids used for expression
experiments in C. elegans were sequenced by custom sequencing
(SeqLab Laboratories Goettingen, Germany), ensuring that the
coding sequences and the ligation sites were intact. For an
overview of constructs used for the transformation experiments
refer to Table S2 (supporting data).
Sequences were analysed using the Sci Ed Central Align Plus
5 software, version 5.04 (Scientific and Educational Software;
Cary, NC, USA), and the NCBI BLAST [30]. The predicted
SLO-1 amino acid sequences and selected sequences of
potassium channels of other species revealed by the BLAST
search were aligned using the ClustalX2 [31] software package
with default settings except that the alignment parameters were
changed to BLOSUM. ClustalX2 calculates scores as percent-
ages of the number of identities in the best alignment divided by
the number of residues compared, excluding gap positions. The
alignment constructed was manually edited and, after elimina-
tion of all positions containing gaps, a phylogenetic tree was built
using bootstrap analysis (1000 replicates) and the Neighbour
Joining method by the Mega4 software package [32] using the
default Poisson correction model for multiple substitutions at the
same site and assuming homogenous substitution rates for all
sites. The analysis of the putative promoter regions was
performed using the Genome2Promoter and MatInspector
software packages (Genomatix, Munich, Germany). The putative
slo-1 promoters of the three nematode species were compared by
alignments using the BLAST bl2seq (filter inactivated for low
complexity regions) [30].
Maintenance of C. elegans
The C. elegans strains were grown on nematode growth medium
(NGM) agar plates containing 50 ml of E. coli (OP50) overnight
culture as a food source at 20uC or room temperature. Strains
employed were Bristol N2 and NM1968 slo-1(js379)V [21]. The
latter contains a mutation within the transmembrane region of the
SLO-1 channel which leads to the early termination of the protein
and is therefore predicted to encode a non-functional ion-channel.
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Thus, slo-1(js379) animals show a slo-1 null phenotype due to a
translational knock-out.
Preparation of assay plates
Emodepside was prepared as five different stock solutions (2 mM
to 200 nM) in ethanol. 0.5 ml of stock solution was added to 100 ml
NGM agar after autoclaving and at a temperature of 42uC.
Accordingly, control plates were prepared containing 0.5 ml ethanol
per 100 ml NGM agar, leading to a final concentration of 85 mM
ethanol. This ethanol concentration does not significantly impair C.
elegans locomotion [33,34]. All plates were seeded with 50 ml E. coli
OP50. In some of the experiments, agar plates also contained 1 mM
penitrem A (Enzo Life Sciences, Lo¨rrach, Germany) in 28 mM
DMSO (final concentration) or only the DMSO vehicle as control.
For the body bend counts, experiments were performed in the
absence of E. coli, i.e. on plain un-seeded NGM plates.
Transformation of C. elegans
Hermaphrodite C. elegans were transformed by microinjection of
plasmids into the gonads. Transformation with the differentially
modified pBK3.1 plasmids (30 ng/ml) was accomplished by co-
injecting the pPD118.33 (Addgene plasmid: 1596; 50 ng/ml) GFP-
expressing marker. Successful transformation was determined by
identification of the selection marker. For the behavioural and
pharmacological analysis only worms carrying the selection
marker were used as they were predicted to express the transgene
of interest as well.
Confirmation of transcription
To confirm the transcription of the introduced slo-1 coding
sequences in transgenic worms, RT-PCR was performed. Total
RNA was isolated from a bulk of worms using the TriFast method
(PeqLab), and contaminating DNA was removed by a DNase I
treatment. 1 mg of total RNA was used for cDNA synthesis
(RevertAid First Strand cDNA Synthesis Kit, Fermentas, St.Leon-
Rot, Germany), and a -RT control (lacking the Reverse
Transcriptase) was performed for each sample. PCR was
performed using 1 ml of template in a 25 ml setup (High Fidelity
PCR Enzyme Mix, Fermentas, St.Leon-Rot, Germany). Each
cDNA was analyzed with all test primer pairs. For primer
sequences refer to Table S3 (supporting data).
Behavioural analysis
The C. elegans slo-1 knockout strain NM1968 slo-1(js379)V shows
an abnormal behaviour of locomotion in terms of increased
reversals, i.e. to stop and reverse direction [21]. To analyse the
impact of the heterologously expressed SLO-1 on this behaviour,
the number of reversals was counted for all lines. Therefore, a total
of 10 L4 stage larvae of each line were selected and placed on an
OP50 seeded NGM agar plate. After 24 hours the young adult
worms were transferred separately away from the bacterial lawn
for one minute to allow removal of bacteria adherent to the worm.
Then the worm was put on an un-seeded NGM-agar plate, and,
after one minute of acclimatisation, the reversals were counted for
3 min. Numbers of body bends per minute and of reversals in
different C. elegans lines were compared using One-Way-ANOVA
and individual lines were then compared with Tukey’s post hoc
test implemented in GraphPad Prism. A p-value ,0.05 was
considered as statistically significant.
Locomotion assays
For locomotion assays L4 stage larvae of stable lines (at least F2
generation) were used. For each strain (transformed and control
strains) ten worms were analysed for each concentration of
emodepside (1 nM, 100 nM, 1 mM, and 10 mM, and in case of
expression from the parasite promoters also 100 mM) and the
ethanol control, respectively. The assays were repeated using two
independent stable lines, so that in total 20 worms for each
construct and concentration were analysed. The experiments were
not repeated for the worms expressing the A. caninum slo-1 from the
C. elegans slo-1 and snb-1 promoters due to the lack of sufficient
numbers of transformants. The setup for the locomotion assay was
as follows: L4 stage larvae of N2, slo-1(js379) and the transformed
slo-1(js379) lines were transferred to NGM plates containing E. coli
OP50 and either different concentrations of emodepside (10 mM to
1 nM) or ethanol vehicle. Worms were maintained on emodepside
or control plates for 24 hours at 20uC and locomotion was
examined afterwards. For that purpose, worms were transferred
for one minute to plain un-seeded NGM plates to remove bacteria.
Subsequently, the worms were transferred to a fresh un-seeded
NGM plate and, after one minute, body bends were counted for
each worm for another minute. A single body bend is defined as
one full sinusoidal movement of the worm. For analysis of a
transformant line at a certain concentration of emodepside, N2
and slo-1(js379) worms were tested on the same day as parallel
controls.
For statistical comparisons, four-parameter logistic concentra-
tion-response-curves with variable slope were fitted using Graph-
Pad Prism 5.0 after plotting the log10 of the emodepside
concentration vs. the relative body bend activity at that
concentration (percentage of maximum number of body bends
in each data set). Bottom values were always constrained to greater
than 0. Top values, Hill slopes and EC50 were not constrained.
Calculation of means and 90% confidence intervals and statistical
tests for differences in 1) EC50, 2) bottom or 3) all four parameters
(top, bottom, Hill slope, and EC50) were also done using
GraphPad Prism. For slo-1(js379), linear regression including
testing for linearity and a significance test for a slope differing from
0 was performed with the same software. Statistical significance
was assumed for p,0.05.
Larval migration inhibition assay
Infective larvae of A. caninum (non-exsheathed) were incubated
for 24 h at room temperature in 16PBS buffer containing either
penitrem A or the vehicle dimethylsulfoxide (DMSO) in
combination with different concentrations of emodepside or the
respective vehicle ethanol. Penitrem A (500 mM stock solution in
DMSO) was used in a final concentration of 1 mM penitrem A,
resulting in a final DMSO concentration of 28 mM (0.2%).
Emodepside (1 mM stock solution in ethanol) was used in final
concentrations of 1 mM, 5 mM, and 10 mM, respectively. The final
ethanol concentration was 170 mM (1%) in these experiments.
The concentration of the vehicles was adjusted to the same final
concentration in all setups by adding DMSO and/or ethanol.
Furthermore, one control was performed without vehicles to
estimate the impact of the vehicles. After 24 h, the larvae were
used for a modified larval migration inhibition test (LMIT), similar
to that described by Demeler et al. [35]. Briefly, 1800 ml
containing approximately 100 larvae was pipetted onto precision
sieves (mesh size 20 mm) in a 24 well plate. The volume of 1800 ml
was sufficient that the sieves were hanging in the liquid and motile
larvae were able to penetrate the meshes. After further incubation
for 24 h at room temperature, the sieves were removed and the
bottom side was carefully rinsed with approximately 300 ml
16PBS to gather any adherent larvae. Thus, this well contained
the migrated larvae. Then, the sieves were turned upside down,
and each sieve was rinsed by carefully pipetting 1000 ml 16PBS
Parasitic Nematode SLO-1-Channels and Emodepside
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through the sieve meshes and collecting the buffer in a so far
empty well to recover the non-migrated larvae. For each setup,
migrated and non-migrated larvae were counted individually, and
the percentage of migrated larvae was calculated as follows:
Migration %ð Þ~migrated larvae =
migrated larvaez non{migrated larvaeð Þ| 100
Each setup was performed in triplicate, and the whole experiment
was performed three times in total. The results were compared to
each other using a One-Way-ANOVA followed by a Tukey’s post
hoc test (GraphPad Prism) A p-value ,0.05 was considered to be
statistically significant.
Accession numbers
Nucleotide sequences: C. elegans YAC clone Y51A2D containing
the putative slo-1 promoter region (AL021497); C. elegans slo-1
splice variant b (NM_001029089); partial coding sequence of A.
caninum slo-1 (CW974961); partial coding sequence of H. contortus
slo-1 (genome version 20060127: contigs .004261, .0045106,
.001213, and .057289); A. caninum slo-1 complete coding
sequence (EU828635); C. oncophora slo-1 complete coding sequence
(EF494185); H. contortus slo-1 complete coding sequence
(EF494184);
Proteins sequences: C. elegans SLO-1a (AAL28102); C. elegans
SLO-1b (AAL28103); C. elegans SLO-1c (AAL28104); C. briggsae
hypothetical protein CBG12923 (XP_001675579.1); A. caninum
SLO-1 (EU 828635); C. oncophora SLO-1 (EF494185); H. contortus
SLO-1 (EF494184); Ixodes scapularis putative calcium-activated
potassium channel (EEC10339.1); Cancer borealis calcium-activated
potassium channel (AAZ80093.4); Manduca sexta calcium-activated
potassium channel alpha subunit (AAT44358.1); Pediculus humanus
corporis putative calcium-activated potassium channel alpha
subunit (EEB13088.1); Drosophila melanogaster slowpoke, isoform P
(NP_001014652.1); Tribolium castaneum predicted protein similar to
slowpoke CG10693-PQ (XP_968651.2); Aplysia californica high
conductance calcium-activated potassium channel (AAR27959.1);
Xenopus laevis potassium large conductance calcium-activated
channel, subfamily M, alpha member 1 (NP_001079159.1); Danio
rerio novel calcium activated potassium channel (CAX13266.1);
Trachemys scripta calcium-activated potassium channel
(AAC41281.1); Gallus gallus calcium-activated potassium channel
alpha subunit (AAC35370.1); Monodelphis domestica predicted
protein similar to large conductance calcium-activated potassium
channel subfamily M alpha member 1 (XP_001367795.1); Mus
musculus mSlo (AAA39746.1); Homo sapiens potassium large
conductance calcium-activated channel, subfamily M, alpha
member 1, isoform CRA_d (EAW54600.1); Bos taurus BK
potassium ion channel isoform C (AAK54354.1); Canis familiaris
calcium-activated K+ channel, subfamily M subunit alpha-1
(Q28265.2); Strongylocentrotus. purpuratus predicted protein similar
to calcium-activated potassium channel alpha subunit
(XP_783726.2)
Results
Coding sequences
The search of the Wellcome Trust Sanger Institute H. contortus
EST BLAST server using C. elegans slo-1 as template revealed four
short fragments of 83 – 150 bp (from the contigs 004261 (two
fragments) and 0045106 and 001213) within the coding sequence
and a 599 bp fragment containing the last twenty codons of the
coding sequence, the stop codon, and part of the 39 untranslated
region (UTR) (from contig 057289). Based on these sequences,
primers were designed to amplify the partial coding sequence of H.
contortus slo-1. The same primers were used to amplify the
respective fragment of C. oncophora slo-1. A partial coding sequence
of A. caninum slo-1 was detected in a whole genome shotgun library
fragment (GenBank Acc. No.: CW974961) and primers were
designed, according to that sequence. RACE-PCR completed the
coding sequences and the 59 and 39 UTRs. The full-length coding
sequences were 3309 bp (EU828635; 1103 predicted amino acids)
for A. caninum slo-1, 3333 bp (EF494185; 1111 predicted amino
acids) for C. oncophora slo-1, and 3315 bp (EF494184; 1105
predicted amino acids) for H. contortus. GC-contents of the coding
sequences were 47.1 – 51.9%, molecular weight and isoelectric
point of the proteins were predicted to be 125.02 - 125.88 kDa and
5.77-5.80, respectively. None of the 59 UTR sequences contained
a spliced leader 1 (SL1) sequence. Compared to the predicted
sequences of A. caninum and H. contortus SLO-1, C. oncophora SLO-1
had six additional NH2-terminal amino acids. The identities of the
nucleotide sequences within the coding region were 80% between
A. caninum and C. oncophora, 79% between A. caninum and H.
contortus, and 85% between C. oncophora and H. contortus. Based on
the predicted amino acid sequences, the identities were 95%
between A. caninum and C. oncophora, 95% between A. caninum and
H. contortus, and 98% between C. oncophora and H. contortus. The
splice variants slo-1a, b, and c of the C. elegans slo-1 cDNA coding
sequence were all 73% identical with A. caninum, C. oncophora, and
H. contortus slo-1, respectively. Based on predicted amino acid
sequences, the identities were 87-88% between C. elegans SLO-1
(splice variants SLO-1 a, b, and c) and all three newly identified
parasitic nematode SLO-1 sequences. A phylogenetic tree
(Figure 1) shows the relationship of selected SLO channels on
the protein level from several animal genera and species. All
known nematode SLO-1 orthologues group together: however,
within this nematode SLO-1 group, the predicted SLO-1 proteins
of the parasitic nematodes cluster in a group distinct from the non-
parasitic nematodes C. elegans and Caenorhabditis briggsae. Analysing
EST and genome databases for putative SLO-1 orthologues in
other nematodes, fragments of coding sequences were identified
for a range of species, including Brugia malayi, Trichinella spiralis,
Strongyloides ratti, and Trichuris muris (data not shown). As these
sequences were either incomplete or of insufficient quality, they
were not included in the phylogenetic analysis.
Analysis of the putative slo-1 promoter sequences
The amplified putative promoter sequences covered approxi-
mately 3 kb upstream of the start codon (A. caninum slo-1 promoter
2997 bp, C. oncophora slo-1 promoter 3421 bp, C. elegans slo-1
promoter 3084 bp). The 59 UTR of A. caninum slo-1 included an
intron, which was not present in C. oncophora slo-1. The sequence
analysis identified no known promoter elements or transcription
factor binding sites in any of the slo-1 promoters employed. Just a
few consensus sequences were detected, which might indicate
RNA polymerase binding sites. No TATA or CAAT elements
could be detected. Comparison of the putative slo-1 promoters of
the three nematode species by alignments did not reveal any
significant similarities. Comparing the sequences with the
respective putative promoter regions of C. briggsae and Caenorhabditis
remanei slo-1 (3000 bp upstream of the start codon) also revealed no
significant similarities (data not shown).
Confirmation of transcription
In cDNA samples of all analysed transgenic lines, transcripts of
the respective expression construct were detected. The primer
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Figure 1. Phylogenetic tree of SLO-1 amino acid sequences and related potassium channels. The tree was calculated using Neighbour
Joining method. Numbers at the branches indicate bootstrap values (in %, 1000 replicates). The bar shows number of substitutions per mutation site.
The selected sequences (GenBank accession numbers in brackets) are as follows: C. elegans SLO-1a (AAL28102); C. elegans SLO-1b (AAL28103); C.
elegans SLO-1c (AAL28104); C. briggsae hypothetical protein CBG12923 (XP_001675579.1); A. caninum SLO-1 (EU828635); C. oncophora SLO-1
(EF494185); H. contortus SLO-1 (EF494184); Ixodes scapularis putative calcium-activated potassium channel (EEC10339.1); Cancer borealis calcium-
activated potassium channel (AAZ80093.4); Manduca sexta calcium-activated potassium channel alpha subunit (AAT44358.1); Pediculus humanus
corporis putative calcium-activated potassium channel alpha subunit (EEB13088.1); Drosophila melanogaster slowpoke, isoform P (NP_001014652.1);
Tribolium castaneum predicted protein similar to slowpoke CG10693-PQ (XP_968651.2); Aplysia californica high conductance calcium-activated
potassium channel (AAR27959.1); Xenopus laevis potassium large conductance calcium-activated channel, subfamily M, alpha member 1
(NP_001079159.1); Danio rerio novel calcium activated potassium channel (CAX13266.1); Trachemys scripta calcium-activated potassium channel
(AAC41281.1); Gallus gallus calcium-activated potassium channel alpha subunit (AAC35370.1); Monodelphis domestica predicted protein similar to
large conductance calcium-activated potassium channel subfamily M alpha member 1 (XP_001367795.1); Mus musculus mSlo (AAA39746.1); Homo
sapiens potassium large conductance calcium-activated channel, subfamily M, alpha member 1, isoform CRA_d (EAW54600.1); Bos taurus BK
potassium ion channel isoform C (AAK54354.1); Canis familiaris calcium-activated K+ channel, subfamily M subunit alpha-1 (Q28265.2);
Strongylocentrotus. purpuratus predicted protein similar to calcium-activated potassium channel alpha subunit (XP_783726.2).
doi:10.1371/journal.ppat.1001330.g001
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pairs targeting the expression constructs containing slo-1 coding
sequences of the other species gave no amplicon in PCR. In cDNA
samples of the slo-1 null mutant strain slo-1(js379) – representing
the genetic background of the transgenic strains – and in the
Bristol N2 wild-type strain, no transcript of any expression
construct could be detected, confirming the authenticity of the
PCR results for the transgenic lines. To ensure that the absence of
specific PCR products was not due to insufficient RNA-isolation or
cDNA-synthesis, a control primer pair was used and gave a PCR
product in all analysed cDNA samples (data not shown).
Behavioural phenotype of transgenic C. elegans
In all transgenic strains expressing functional slo-1 from one of
the expression constructs, the phenotype of increased reversals
exhibited by the slo-1 null mutant strain slo-1(js379) was
completely rescued as the rate of reversals was statistically not
significantly different (p = 0.87 in a one-way ANOVA) from that
observed in Bristol N2 wild-type worms (Figure 2A) but
significantly (p,0.001) lower than in mutant slo-1(js379).
Functional expression of parasitic nematode slo-1 in
C. elegans
It was previously shown that C. elegans slo-1 loss-of-function
mutants are highly resistant to the inhibition of locomotion
behaviour by emodepside [20]. In our study, we expressed slo-1
orthologues of the parasitic nematodes A. caninum and C. oncophora
in the emodepside-resistant slo-1(js379) genetic background in
order to rescue sensitivity to emodepside and to investigate
involvement of these proteins in the mode of action of emodepside.
Locomotion was determined by measuring body bends of the
worms in the absence of food. By transformation of C. elegans slo-
1(js379), stable transgenic lines were obtained expressing 1) A.
caninum slo-1 from the neuronal snb-1 promoter, 2) C. oncophora slo-1
from the snb-1 promoter, 3) A. caninum slo-1 from the C. elegans slo-1
promoter, 4) C. elegans slo-1 from the C. elegans slo-1 promoter 5) A.
caninum slo-1 from the A. caninum slo-1 promoter, and 6) C. oncophora
slo-1 from the C. oncophora slo-1 promoter (an overview is given in
supporting data, Table S2). Transgenic lines were analysed for
their susceptibility to emodepside. Their locomotion behaviour
was compared to that of the wild-type strain Bristol N2 and to that
of the loss-of-function mutant slo-1(js379) over a wide range of
emodepside concentrations and concentration-response-curves
were fitted to the data to allow statistical comparisons.
Animals of all analysed lines showed a comparable basic
locomotion, measured as body bends per minute, on the control
plates without emodepside (Figure 2B). Locomotion of the slo-
1(js379) mutant strain was not at all affected by any of the
emodepside concentrations tested (Figure 3) as revealed by
concentration-response-curves that are not significantly different
from a straight line with slope 0 (p= 0.91). In contrast, locomotion
Figure 2. Behavioural phenotype of transgenic C. elegans. (A) number of reversals in 3 min were counted on NGM agar without bacteria for N2
Bristol, slo-1(js379) and the indicated transgenic lines derived from slo-1(js379). All values are means + SD. An asterisk (*) marks significant differences
to all other lines (p,0.001) determined by One-Way-ANOVA followed by Tukey’s test. (B) number of body bends per minute counted on NGM agar
without bacteria. One-Way-ANOVA revealed no significant differences between different lines. N2, N2 Bristol wild-type strain; js379, slo-1(js379)
mutant strain; Cel-snb-1::Aca-slo-1, line expressing A. caninum slo-1 from the C. elegans snb-1 promoter; Cel-snb-1::Con-slo-1, line expressing C.
oncophora slo-1 from the C. elegans snb-1 promoter; Cel-slo-1::Aca-slo-1, line expressing A. caninum slo-1 from the C. elegans slo-1 promoter; Cel-slo-
1::Cel-slo-1, line expressing C. elegans slo-1 from the C. elegans slo-1 promoter; Aca-slo-1::Aca-slo-1, line expressing A. caninum slo-1 from the A.
caninum slo-1 promoter; Con-slo-1::Con-slo-1, line expressing C. oncophora slo-1 under control of the C. oncophora slo-1 promoter.
doi:10.1371/journal.ppat.1001330.g002
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of the Bristol N2 wild-type strain was concentration-dependently
inhibited by emodepside. The EC50 for this effect varied between
127.3 nM and 144.2 nM (Table 1) in this set of experiments. At
the highest concentration used (10 mM), the Bristol N2 wild-type
worms were nearly completely paralysed or dead. The transgenic
worms expressing A. caninum (Figure 3A) or C. oncophora (Figure 3B)
slo-1 from the snb-1 promoter showed significantly different
concentration-response-curves (p,0.0001) with increased suscep-
tibility to emodepside compared to the slo-1(js379) mutant but
were not as susceptible as Bristol N2 wild-type animals. Although
the EC50 values were not altered, the lines expressing parasitic
nematode slo-1 from the snb-1 promoter showed significantly
increased bottom values (refer to Table 1) indicating that even
extremely high emodepside concentrations were not able to cause
complete paralysis. At the highest concentration of 10 mM, worms
of the transgenic lines were still able to show nearly half the body
bend activity as the ethanol control, while the wild-type worms
were almost completely immobilised. Expression of A. caninum slo-1
from the C. elegans slo-1 promoter (Figure 3C) showed a marked
susceptibility to emodepside that was equivalent to N2 wild-type
worms: worms expressing the parasite slo-1 from the C. elegans slo-1
promoter in slo-1(js379) animals fully restored susceptibility to
emodepside as revealed by the absence of any significant
differences in top and bottom values, Hill slope or EC50
(Table 1). A comparable effect was observed when the emodepside
susceptibility of the slo-1(js379) mutant was rescued through the C.
elegans slo-1 from the C. elegans slo-1 promoter (Figure 3D and
Table 1).
Transgenic worms expressing A. caninum or C. oncophora slo-1
from the respective A. caninum or C. oncophora slo-1 promoter
showed increased susceptibility to emodepside compared to the slo-
1(js379) mutant as well (Figure 4). However, the observed
concentration-dependent effects were not as marked as seen for
the transgenic worms expressing slo-1 from the C. elegans slo-1
promoter. The lines expressing A. caninum or C. oncophora slo-1 from
the A. caninum or C. oncophora slo-1 promoter showed a 62- and 72-
fold higher EC50 than the wild type worms. EC50 and 95%
confidence intervals and significance levels for comparisons are
given in Table 2.
In all experiments, the susceptibility appeared not only as a
simple reduction of the number of body bends, but also as an
altered pattern of movement, since the worms seemed to be
Figure 3. Parasite SLO-1 expressed from C. elegans promoters recover emodepside susceptibility in resistant slo-1 loss-of-function
mutants. Body bend activity in percent (relative to the highest number of body bends in that group) of young adults after 24 h exposure to
emodepside. Comparison of wild-type N2, emodepside-resistant strain slo-1(js379), and transformed slo-1(js379) lines. Error bars represent standard
errors of the mean. Dots (N) represent transformed lines, squares (&) N2 Bristol wild-type strain, triangles (m) js379(slo-1) mutant strain. (A) Cel-snb-
1::Aca-slo-1, line expressing A. caninum slo-1 from the C. elegans snb-1 promoter. (B) Cel-snb-1::Con-slo-1, line expressing C. oncophora slo-1 from the C.
elegans snb-1 promoter. (C) Cel-slo-1::Aca-slo-1, line expressing A. caninum slo-1 from the C. elegans slo-1. (D) Cel-slo-1::Cel-slo-1, C. elegans slo-1
expressed from C. elegans slo-1 promoter.
doi:10.1371/journal.ppat.1001330.g003
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stiffened in the forepart of their body. None of the transformed
strains showed coiling as was observed previously at 1 mM
emodepside after transformation of slo-1(js379) with pBK3.1, the
plasmid containing the C. elegans slo-1 coding sequence and the snb-
1 promoter [20]. To conclude, a total functional rescue of the
wild-type phenotype regarding the inhibitory effect of emodepside
on locomotion was achieved with heterologous slo-1 genes
expressed under the control of the C. elegans slo-1 promoter in C.
elegans, as revealed by our statistical analysis showing no significant
differences in the four parameters of the logistic concentration-
response curve. These findings provide evidence that the slo-1
genes cloned from A. caninum and C. oncophora are functional, as
well as structural, orthologues of C. elegans slo-1.
Inhibition of endogenous SLO-1 in A. caninum and
C. elegans
The vehicles DMSO and ethanol in the concentrations used
here did not have any statistically significant effect on the
migration of A. caninum larvae through 20 mm meshes. In the
presence of emodepside, a concentration-dependent inhibition of
migration was observed (Figure 5A). The additional presence of 1
mM penitrem A clearly antagonized the effect of emodepside on
migration. The difference in migration of larvae incubated with
emodepside either with or without penitrem A was statistically
highly significant with p-values of ,0.001 for all emodepside
concentrations tested. Body-bend assays with C. elegans worms
produced highly similar results (Figure 5B).
Discussion
In the present study, we identified orthologues of the Ca2+-
activated K+ (BK) channel C. elegans slo-1 in the parasitic
nematodes H. contortus, C. oncophora, and A. caninum. Subsequently,
we analysed the ability of A. caninum and C. oncophora slo-1 to
functionally rescue emodepside susceptibility in slo-1 knockout
mutant C. elegans. The examination of anthelmintic targets of
parasitic nematodes is of great importance, since, in contrast to
their orthologues in C. elegans, they are the direct targets for drugs
used in veterinary and human medicine. Unfortunately, the
parasitic stages of the nematodes, which mainly represent the
target population for drugs, cannot be examined easily, and
especially functional analysis of gene products in parasitic
nematodes is usually not feasible. Up to now, parasitic nematodes
cannot be maintained in in vitro cultures for their complete life
cycle. Therefore, although it has been occasionally successful in
some species such as filaria or Strongyloides spp. [36-38], genetic
engineering, i.e. expression or knockout of genes, in parasitic
nematodes is still an unsolved problem [39]. RNAi experiments in
parasitic nematodes had very variable outcomes, depending on the
target gene, the delivery method, and the species tested [40–44].
This might be due to the fact that parasitic nematodes seem to lack
orthologues for a transporter responsible for the systemic spread of
RNAi in C. elegans, facilitating the accessibility of cells for RNAi in
the latter [45]. Therefore, the use of C. elegans as a model and
expression system is currently one of the most powerful tools for
Table 1. A summary of the pharmacological response to emodepside in transgenic lines expressing either C. elegans or parasite
slo-1 under the control of C. elegans-derived promoters.
Strain/line* N2# Cel-snb-1::Aca-slo-1 N2 Cel-snb-1::Con-slo-1
Hill slope -0.74 -0.85 -0.83 -0.53
95% confidence interval -0.94 to -0.54 -1.32 to -0.37 -1.07 to -0.58 -0.82 to -0.23
EC50 [mM] 0.1442 0.1972 0.1285 0.2397
95% confidence interval [mM] 0.11 to 0.2 0.01 to 0.42 0 to 0.19 0 to 0.82
Bottom [%] 0 45.67 2.0 34.36
95% confidence interval [%] 0.0 to 7.42 36.36 to 54.99 0.0 to 9.96 16.80 to 51.93
R2 0.96 0.83 0.95 0.76
p (4 parameters)x ,0.0001 , 0.0001
p (EC50)
x 0.4367 0.3458
p (bottom)x 0.0012 0.0263
Strain/line* N2# Cel-slo-1::Aca-slo-1 N2 Cel-slo-1::Cel-slo-1
Hill slope -0.74 -0.85 -0.77 -0.78
95% confidence interval -0.94 to -0.54 -1.123 to -0.57 -0.94 to -0.60 -0.93 to -0.63
EC50 [mM] 0.14 0.15 0.13 0.13
95% confidence interval [mM] 0.11 to 0.2 0.10 to 0.23 0.09 to 0.19 0.09 to 0.17
Bottom [%] 0 1.884 1.482 0
95% confidence interval [%] 0.0 to 7.4 0.0 to 10.96 0.0 to 7.7 0.0 to 6.20
R2 0.9550 0.9382 0.9438 0.9507
p (4 parameter)x 0.8310 0.9229
The data given are the Hill slope, EC50 and bottom values for the four parameter logistic inhibition curves with 95% confidence intervals. Top values were always close
to 100% due to normalization to the highest absolute value in each data set. The values were determined from pooled data for 3 experiments.
#For both A. caninum experiments, the same N2 control was used.
*Since all curves were significantly different from slo-1(js379) (p,0.0001), which did not show a concentration-dependent response at all, this comparison is not listed
here.
xComparisons were done for all four parameters of a concentration-response-curves (Hill slope, EC50, top and bottom). If significant differences were obtained with this
calculation, separate comparisons for EC50 and bottom followed.
doi:10.1371/journal.ppat.1001330.t001
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the functional analysis of genes of parasitic nematodes, especially if
the genes have close orthologues in C. elegans [39].
One approach is the overexpression of a parasitic nematode
gene in C. elegans with a wild-type genetic background for the
respective gene. This approach can be used if the knockout mutant
phenotype for the gene to be examined is lethal or not evident.
Couthier et al. [46] expressed the H. contortus transcription factor
elt-2 ectopically in C. elegans and found that this expression had
similar effects as ectopic expression of the endogenous elt-2.
Another experimental setup is exemplified by the experiments
described here for slo-1, namely the rescue of the C. elegans loss-of-
function mutant by expression of the homologous gene of a
parasitic nematode. For that purpose, the mutant should have a
clear phenotype and the effects of the rescue should be
measurable. Similar experiments examining functionality of
parasitic nematode genes in C. elegans have been performed
previously. In the study of Kwa et al. [47], ß-tubulin (isotype 1) of
H. contortus was expressed in benzimidazole-resistant mutants of C.
elegans (TU1054 ben-1(u462)). The benzimidazole-resistance of the
ben-1(u462) C. elegansmutants is due to a mutation disrupting the ß-
tubulin gene ben-1 [47,48]. The mutants showed a significantly
higher EC50 with regard to the benzimidazole thiabendazole in a
larval development inhibition assay compared to the wild-type
Bristol N2. In contrast to the resistant ben-1 mutants, H. contortus ß-
tubulin expressing ben-1(u462) mutants showed a lower EC50,
though not as low as the wild-type larvae [47]. Thus, a total rescue
of the wild-type phenotype regarding the effect of thiabendazole
on egg-development was not achieved. The effect of expression of
H. contortus ß-tubulin on susceptibility of adult ben-1(u462) worms
to benzimidazoles has not been reported. Cook et al. [49]
expressed the a-subunit of the glutamate-gated chloride channel
(GluCla) of H. contortus in C. elegans GluCla mutants, which show a
lower sensitivity to ivermectin and a decreased duration of forward
movement. Here, a rescue of the wild-type phenotype in respect of
the natural locomotion behaviour was observed. However, the
effect of ivermectin was not described. Another study showed that
expression of the transcription factor of the FOXO/FKH family
of Strongyloides stercoralis in C. elegans daf-16 mutants was able to
rescue the dauer-forming capability [50]. Very recently, the
acetylcholinesterase of the plant-parasitic nematode Globodera
pallida was expressed in C. elegans and was shown to functionally
rescue the phenotype of the C. elegans double mutant ace-1;ace-2
[51]. In another recent study, Gillan et al. expressed the heat-
shock protein 90 (hsp-90) of H. contortus and Brugia pahangi in C.
elegans. While expression of H. contortus hsp-90 in C. elegans daf-21
heat shock protein 90 mutants (C. elegans daf-21(nr2081)) partially
rescued the phenotype of the mutant, the B. pahangi hsp-90 failed to
do so, although the construct was transcribed and translated [52].
The great advantage of C. elegans as an expression system for
parasite genes is that posttranslational modifications of recombi-
nantly expressed proteins, which can be necessary for the
biological function of the protein, are more conserved between
nematodes than between nematodes and standard expression
systems [53]. In our experiments, we did not use the recombi-
nantly expressed protein, but the whole transgenic organism to
measure the influence of the heterologously expressed proteins on
susceptibility to emodepside.
The expression of A. caninum slo-1 and C. oncophora slo-1 in the
emodepside-resistant C. elegans slo-1(js379) mutant fully rescued the
phenotype of worm locomotion: transgenic worms no longer
showed increased reversal movement. These findings indicate a
complete functional rescue and at least sufficient expression to
restore SLO-1 dependent signalling to wild-type levels in the
locomotor circuits. The subsequent pharmacological analysis
showed that the transgenesis also rescued the phenotypic
behaviour of the animals in terms of inhibited locomotion activity
in the presence of emodepside. Animals expressing parasitic
nematode slo-1 driven by the snb-1 promoter responded to
emodepside in a manner qualitatively similar to wild-type animals,
although the inhibition of locomotion was significantly weaker
than that of the wild-type worms as determined by counting body
bends. No complete paralysis was obtained even with an
emodepside concentration that completely paralysed the wild-type
animals. This phenotype might reflect the fact that expression of
slo-1 was only reconstituted in one of its normal compartments,
neuronal cells, whereas it was absent from another compartment,
Figure 4. Parasite SLO-1 expressed from parasite-derived slo-1
promoters partially recover emodepside susceptibility in
resistant slo-1 loss-of-function mutants. Body bend activity
(relative to the highest number of body bends in each group) of
young adults after 24 h exposure to emodepside. Comparison of wild-
type N2, emodepside-resistant strain slo-1(js379), and transformed slo-
1(js379) lines. Dots (N) represent Aca-slo-1::Aca-slo-1 lines (expressing A.
caninum slo-1 from the putative A. caninum slo-1 promoter); inverted
triangles (.) Con-slo-1::Con-slo-1 lines (expressing C. oncophora slo-1
from the putative C. oncophora slo-1 promoter); squares (&) N2 Bristol
wild-type strain, triangles (m) js379(slo-1) mutant strain.
doi:10.1371/journal.ppat.1001330.g004
Table 2. Hill slope, EC50 and bottom value with 95%
confidence intervals for transgenic lines expression slo-1
under control of a parasitic nematode-derived promoter.
Strain/line* N2
Aca-slo-1::
Aca-slo-1
Con-slo-1::
Con-slo-1
Hill slope -0.84 -0.45 -0.43
95% confidence interval -1.28 to -0.40 -0.76 to -0.16 -1.1 to 0.23
EC50 [mM] 1.626 117.8 100.9
95% confidence interval [mM] 0.97 to 2.72 2.49 to 5578 0 to 70440000
Bottom [%] 0 0 0
95% confidence interval [%] 0.0 to 10.36 0.0 to 81.98 0.0 to 294.6
R2 0.95 0.68 0.42
p (EC50 vs. N2) , 0.0001 0.0031
p (4 parameter vs. N2) , 0.0001 , 0.0001
*Since all curves were significantly different from slo-1(js379) (p,0.0001), which
did not show a concentration-dependent response at all, this comparison is
not listed here.
doi:10.1371/journal.ppat.1001330.t002
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the muscle cells. The findings with parasite slo-1 under control of
the snb-1 promoter are similar to previous experiments, in which
C. elegans slo-1(js379) mutants were rescued by expression of
endogenous slo-1 from the snb-1 promoter [20]. Interestingly, the
coiled paralysis of the transgenic C. elegans upon exposure to
emodepside observed in earlier experiments with the snb-1
promoter driven expression and also with the combination of
snb-1 and myo-3 promoter driven expression of the endogenous slo-
1 was not observed in our experiments. The coiling previously
observed for slo-1(js379) animals expressing slo-1 from the snb-1
promoter in the presence of 1 mM emodepside was supposed to be
due to overexpression or to ectopic expression in neurons usually
not expressing slo-1 [20]. The most likely reason for the absence of
this phenotype in the present study is the altered plasmid used for
transformation. Although the linkage between the promoter and
the slo-1 coding sequence was identical for the plasmids carrying
the parasite slo-1 and the parental pBK3.1 plasmid used in the
previous study, the downstream coding sequence may have
influenced the level of expression. While the earlier study by
Guest et al. [20] aimed to determine whether the mediation of the
effects of emodepside is controlled via a neuronal or a muscular
pathway, we were now interested in whether the parasitic
nematode SLO-1 channels were also able to act as key
components for emodepside action. Therefore, we chose to
express the parasite slo-1 not only from the neuronal promoter
snb-1, which showed a stronger effect in that former study than the
muscle-specific promoter myo-3, but also from the putative
endogenous C. elegans slo-1 promoter to achieve a pattern
resembling the natural expression pattern, and from the putative
parasite slo-1 promoters to test their ability to drive expression in
C. elegans. The constructs were designed to be comparable to the
pBK3.1 construct, which carries the snb-1 promoter sequence,
2987 bp in size.
The transgenic animals expressing parasitic nematode slo-1
driven by the C. elegans slo-1 promoter were highly susceptible to
emodepside, and since their susceptibility was statistically not
different from the susceptibility of the wild-type worms, we
considered this phenotype as a full rescue. For some drug
targets, such as b-tubulin, a single nucleotide polymorphism can
abolish their functionality as a drug target [54]. Therefore, the
overall sequence identity between parasite and C. elegans SLO-1
orthologues of 87-88% per se did not ensure a conserved function
with regard to emodepside. In the study of Gillan et al. the H.
contortus hsp-90 sequence showed 88% identity with the C. elegans
orthologue, but its expression rescued the mutant phenotype
only partially [52]. The finding that expression of slo-1 from
different nematode species restored the susceptibility to emodep-
side in the slo-1(js379) mutants emphasises that the mode of
action is most likely conserved between these species. Generally,
SLO-1 channels belong to a relatively conserved ion channel
family [23]. This was also confirmed by our BLAST search
results, which identified channels in very distantly related
genera.
The expression of parasite slo-1 under control of the putative slo-
1 promoters from A. caninum and C. oncophora aimed to examine the
capacity of the parasite-derived promoters to drive expression of
Figure 5. Effect of penitrem A and emodepside on nematode locomotion. (A) Migration of infective A. caninum larvae (relative to negative
control without vehicle) through a 20 mm precision sieve after incubation in different concentrations of emodepside in presence or absence of
penitrem A. (B) Body bend activity of C. elegans (relative to negative control without vehicle). (A, B) Negative control (black bar), without vehicle or
substance; vehicle control (light grey bars), with 28 mM DMSO, 170 mM ethanol, and the indicated emodepside concentrations; 1 mM penitrem A
(dark grey bars), with 1 mM penitrem A, 170 mM ethanol and the indicated emodepside concentrations. Error bars represent standard deviations.
Asterisks mark a significant difference between vehicle controls and the experiments with 1 mM penitrem A at the same emodepside concentration
(*** p,0.001) determined by One-Way-ANOVA followed by a Tukey’s pairwise comparison.
doi:10.1371/journal.ppat.1001330.g005
Parasitic Nematode SLO-1-Channels and Emodepside
PLoS Pathogens | www.plospathogens.org 11 April 2011 | Volume 7 | Issue 4 | e1001330
the coding sequence of their natural gene within the heterologous
background of C. elegans. The transformants showed only partial
rescue of emodepside susceptibility. However, in contrast to the
lines with snb-1 driven expression, the lines expressing slo-1 from
the putative slo-1 promoters of A. caninum and C. oncophora,
respectively, did not show increased bottom values. In these
experiments the rescued lines clearly had a higher EC50,
suggesting that the expression pattern might have been qualita-
tively restored but that expression levels in general were too low.
Since, as was shown in our experiments using the C. elegans slo-1
promoter, the coding sequences of parasite slo-1 appeared to be
able to rescue the resistant phenotype completely, the reason for
the incomplete rescue is most likely the promoter.
The lack of TATA or CAAT elements which we observed for
the slo-1 promoters from A. caninum, C. oncophora as well as from C.
elegans is consistent with other studies on nematode promoters and
strengthens the assumption that the absence of these elements is a
characteristic feature of protein-coding genes of this phylum
[26,55-59]. Transcriptional regulatory elements can be located at
large distances from the start codon, within intron sequences, and
also within the 39 UTR. Furthermore, expression can be
influenced by post-transcriptional regulation, e.g. by microRNAs
[60]. Nevertheless, most common reporter gene constructs only
use upstream intergenic sequence, and it is recommended to
include as much of the upstream sequence as possible. Even so, all
phenotypes obtained with such reporter constructs must be
interpreted with caution as they may not necessarily reflect the
endogenous gene expression pattern [61].
We conclude from the present experiments that the parasite
slo-1 promoters drive expression in a functionally appropriate
pattern, as the parasite slo-1 expressed from the respective
parasite slo-1 promoter qualitatively restored emodepside
susceptibility in resistant slo-1(js379) C. elegans. The fact that
the emodepside susceptibility of the transformants was signifi-
cantly lower than in transformants expressing parasite slo-1 from
the C. elegans snb-1 or slo-1 promoter, respectively, in turn
indicates that the expression pattern obtained with the parasite
promoters is not equivalent to that obtained with the C. elegans
promoters used in this study. Interestingly, the phenotype of slo-
1(js379) C. elegans concerning increased reversals was completely
rescued by the parasite slo-1 expressed from the parasite slo-1
promoters. The fact that the rescue regarding emodepside
susceptibility was less complete again strengthens the assumption
that the spatial pattern or some other characteristics of
expression such as expression levels in certain cell types might
not have been sufficient to completely fill in the function of the
wild-type slo-1 expression. An approach to use the slo-1
promoters of C. elegans, A. caninum, and C. oncophora to express
GFP for localisation studies in C. elegans was only partially
successful. Within the offspring of the microinjected hermaph-
rodites only single worms were found exhibiting GFP-expression.
Fluorescence was detected as punctate structures in the pharynx
region of the transformed animals, indicating expression in
pharyngeal neurons, furthermore in the neuron-rich anal region
of the worms and in locations consistent with expression in the
nerve cords (data not shown). For the C. elegans slo-1 promoter
reporter construct, GFP expression was observed in body wall
muscle cells within the forepart of the body (data not shown).
However, due to the restricted number of observations these
investigations thus far do not allow to draw final conclusions and
therefore need to be further pursued.
The hypothesis of the functional involvement of SLO-1 in the
mechanism of action of emodepside in parasites was further
supported by a series of experiments with emodepside and
penitrem A. Penitrem A is a tremorgenic mycotoxin known to
completely suppress bovine BK channel currents at a concentra-
tion of 10 nM [27]. It has also been used as a BK channel inhibitor
in a study on muscle fibres of the liver fluke Fasciola hepatica [62].
The concentration in those experiments was 10 mM, but the
authors do not report, whether they tested other concentrations. In
our experiments, we used penitrem A in a concentration of 1 mM
and showed its ability to antagonise the paralysing effect of up to
10 mM emodepside on A. caninum larvae and young C. elegans
adults. While lower concentrations of penitrem A (10 nM and 100
nM, data not shown) did not impair the effect of 10 mM
emodepside, 1 mM penitrem A antagonised emodepside at all
emodepside concentrations analyzed. The need for higher
penitrem A concentrations than in experiments with cultured
mammalian cells might be explained by a lower accessibility of the
target in the intact nematode larvae, e.g. due to the cuticula – at
least for the non-feeding A. caninum third-stage larvae. Currently
there are no data available on whether penitrem A is indeed also a
specific BK channel inhibitor in nematodes and on what penitrem
A concentrations are needed for this inhibition. However, the
present data show antagonistic effects of emodepside and penitrem
A, indicating that both drugs target the same pathway requiring
SLO-1.
To conclude, the examination of the actual role of SLO-1 in the
signalling of emodepside is still under way. The prevailing view is
that emodepside directly or indirectly activates SLO-1 [20,63]. In
contrast to the effects of emodepside on pharyngeal pumping, the
effects of emodepside on locomotion are not mediated by the
previously described latrophilin-activating pathway [19]. The
current model includes latrophilin and SLO-1 for the pharyngeal
neurons and SLO-1 but not latrophilin for the body wall
musculature [63].
The presented study aimed primarily to test the hypothesis that
the mechanism of action of emodepside as far as currently known
is conserved in nematodes. Our results are based on functional
expression of A. caninum and C. oncophora slo-1 in C. elegans driven
by different promoters and demonstrate the ability of the parasitic
SLO-1 to act in the mode of action of emodepside. These results
are further supported by the experiments with the BK channel
inhibitor penitrem A antagonising emodepside. Therefore the
current findings suggest that the mode of action is conserved
across the three nematode species, providing an important
example for functional analysis of the role of individual parasite
genes as targets for anthelmintic drugs. Furthermore, these
experiments emphasise the potency of C. elegans as an authentic
functional model for expression of parasitic nematode genes – at
least from clade V – and the subsequent physiological
examination of drug/target interactions. Experiments of this
type close the gap between research in model organisms and in
parasitologically relevant target species. The results presented in
this work open new perspectives on functional analysis of
parasitic nematode genes in general and in particular allow
further analysis of putative targets for emodepside and the
elucidation of the mode of action in detail. Transgenic worms
from the present study expressing C. elegans slo-1 driven by the C.
elegans slo-1 promoter have already been used as a control in a
parallel study regarding the expression of the human slo-1
orthologue kcnma1 in C. elegans (Crisford et al., submitted).
Another possible application of the system is its use to analyse the
impact of certain mutations on emodepside susceptibility, for
instance single nucleotide polymorphisms (SNP), identified in
resistant populations and suspected to contribute to resistance
development. In the long-term, these methods might also
enhance development of new anthelmintically active agents.
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Supporting Information
Table S1 Sequences of primers used for amplifying slo-1 coding
sequences and putative promoter regions. The first primer pair for
each target was used to amplify the fragment from cDNA, the
second pair to introduce restriction sites for subcloning. Restriction
sites are indicated by the name of the restriction enzyme in
parentheses after the primer name and are underlined within the
primer sequences.
Found at: doi:10.1371/journal.ppat.1001330.s001 (0.05 MB
DOC)
Table S2 Sequences of primers used for confirmation of
transcription of the expression constructs. Each cDNA was tested
with all primer pairs. * The primer pair Ce slo-1 RT mut Fw/Rv
was used to confirm the success of RNA isolation and cDNA
synthesis. The primers target the slo-1 transcript of C. elegans,
which is also present in the slo-1 knockout strain js379, as the
knockout is a translational one due to a premature stop codon.
Therefore, this primer pair was used to control for successful
cDNA synthesis. It spans the mutated region and can therefore
also be used to amplify the region for sequencing. In contrast, the
primer pair Ce slo-1 RT Fw III/Rv II for confirmation of the
transcription of the C. elegans slo-1 expression construct does not
target the mere coding sequence, but the reverse primer anneals to
the untranslated region (39-UTR) coded by the vector. Therefore,
in untransformed animals no amplification can be achieved using
this primer pair.
Found at: doi:10.1371/journal.ppat.1001330.s002 (0.03 MB
DOC)
Table S3 Overview of constructs used for transformations.
Found at: doi:10.1371/journal.ppat.1001330.s003 (0.04 MB
DOC)
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